nodes	percent_of_prediction	percent_of_DWPC	metapath
Cabazitaxel—ABCG2—Vandetanib—thyroid cancer	0.146	0.294	CbGbCtD
Cabazitaxel—ABCG2—Sorafenib—thyroid cancer	0.0883	0.177	CbGbCtD
Cabazitaxel—ABCG2—Doxorubicin—thyroid cancer	0.0535	0.108	CbGbCtD
Cabazitaxel—CYP3A5—Sorafenib—thyroid cancer	0.0489	0.0983	CbGbCtD
Cabazitaxel—CYP2C8—Sorafenib—thyroid cancer	0.047	0.0945	CbGbCtD
Cabazitaxel—ABCB1—Sorafenib—thyroid cancer	0.0318	0.064	CbGbCtD
Cabazitaxel—CYP3A4—Vandetanib—thyroid cancer	0.0316	0.0636	CbGbCtD
Cabazitaxel—ABCB1—Doxorubicin—thyroid cancer	0.0193	0.0388	CbGbCtD
Cabazitaxel—CYP3A4—Sorafenib—thyroid cancer	0.0191	0.0383	CbGbCtD
Cabazitaxel—CYP3A4—Doxorubicin—thyroid cancer	0.0116	0.0233	CbGbCtD
Cabazitaxel—TUBB8—head—thyroid cancer	0.00423	0.0534	CbGeAlD
Cabazitaxel—TUBA4A—saliva-secreting gland—thyroid cancer	0.00405	0.0511	CbGeAlD
Cabazitaxel—TUBB2B—saliva-secreting gland—thyroid cancer	0.00313	0.0396	CbGeAlD
Cabazitaxel—TUBA4A—trachea—thyroid cancer	0.00312	0.0394	CbGeAlD
Cabazitaxel—TUBB—saliva-secreting gland—thyroid cancer	0.00297	0.0375	CbGeAlD
Cabazitaxel—TUBB2A—saliva-secreting gland—thyroid cancer	0.00295	0.0373	CbGeAlD
Cabazitaxel—TUBB6—saliva-secreting gland—thyroid cancer	0.00291	0.0368	CbGeAlD
Cabazitaxel—TUBB3—head—thyroid cancer	0.00288	0.0364	CbGeAlD
Cabazitaxel—TUBB1—head—thyroid cancer	0.00282	0.0356	CbGeAlD
Cabazitaxel—TUBA4A—Afatinib—Vandetanib—thyroid cancer	0.00274	0.249	CbGdCrCtD
Cabazitaxel—TUBB4B—saliva-secreting gland—thyroid cancer	0.00253	0.032	CbGeAlD
Cabazitaxel—TUBA4A—thyroid gland—thyroid cancer	0.00247	0.0312	CbGeAlD
Cabazitaxel—TUBB3—Afatinib—Vandetanib—thyroid cancer	0.00244	0.222	CbGdCrCtD
Cabazitaxel—TUBB2B—trachea—thyroid cancer	0.00242	0.0305	CbGeAlD
Cabazitaxel—TUBA4A—Gefitinib—Vandetanib—thyroid cancer	0.00239	0.218	CbGdCrCtD
Cabazitaxel—TUBB—trachea—thyroid cancer	0.00229	0.0289	CbGeAlD
Cabazitaxel—TUBB2A—trachea—thyroid cancer	0.00228	0.0288	CbGeAlD
Cabazitaxel—TUBB6—trachea—thyroid cancer	0.00224	0.0284	CbGeAlD
Cabazitaxel—TUBA4A—head—thyroid cancer	0.00219	0.0277	CbGeAlD
Cabazitaxel—TUBB4A—thyroid gland—thyroid cancer	0.00198	0.025	CbGeAlD
Cabazitaxel—TUBB4B—trachea—thyroid cancer	0.00195	0.0247	CbGeAlD
Cabazitaxel—TUBB2B—thyroid gland—thyroid cancer	0.00191	0.0242	CbGeAlD
Cabazitaxel—TUBB—thyroid gland—thyroid cancer	0.00181	0.0229	CbGeAlD
Cabazitaxel—TUBB2A—thyroid gland—thyroid cancer	0.0018	0.0227	CbGeAlD
Cabazitaxel—TUBB6—thyroid gland—thyroid cancer	0.00178	0.0224	CbGeAlD
Cabazitaxel—TUBB4A—head—thyroid cancer	0.00176	0.0222	CbGeAlD
Cabazitaxel—TUBB2B—head—thyroid cancer	0.0017	0.0214	CbGeAlD
Cabazitaxel—TUBB2A—head—thyroid cancer	0.0016	0.0202	CbGeAlD
Cabazitaxel—TUBB6—head—thyroid cancer	0.00157	0.0199	CbGeAlD
Cabazitaxel—TUBB4B—thyroid gland—thyroid cancer	0.00154	0.0195	CbGeAlD
Cabazitaxel—TUBA4A—lymph node—thyroid cancer	0.00153	0.0194	CbGeAlD
Cabazitaxel—TUBB4B—Afatinib—Vandetanib—thyroid cancer	0.00151	0.137	CbGdCrCtD
Cabazitaxel—ABCG2—saliva-secreting gland—thyroid cancer	0.00149	0.0188	CbGeAlD
Cabazitaxel—TUBB4B—head—thyroid cancer	0.00137	0.0173	CbGeAlD
Cabazitaxel—TUBB4A—lymph node—thyroid cancer	0.00123	0.0155	CbGeAlD
Cabazitaxel—TUBB2B—lymph node—thyroid cancer	0.00119	0.015	CbGeAlD
Cabazitaxel—TUBB6—Erlotinib—Vandetanib—thyroid cancer	0.00115	0.105	CbGdCrCtD
Cabazitaxel—TUBB—lymph node—thyroid cancer	0.00112	0.0142	CbGeAlD
Cabazitaxel—TUBB2A—lymph node—thyroid cancer	0.00112	0.0141	CbGeAlD
Cabazitaxel—TUBB6—lymph node—thyroid cancer	0.0011	0.0139	CbGeAlD
Cabazitaxel—TUBB4B—lymph node—thyroid cancer	0.000959	0.0121	CbGeAlD
Cabazitaxel—ABCG2—thyroid gland—thyroid cancer	0.00091	0.0115	CbGeAlD
Cabazitaxel—TUBB6—Afatinib—Vandetanib—thyroid cancer	0.000752	0.0685	CbGdCrCtD
Cabazitaxel—Cellulitis—Epirubicin—thyroid cancer	0.000711	0.00232	CcSEcCtD
Cabazitaxel—Anaemia—Sorafenib—thyroid cancer	0.000706	0.0023	CcSEcCtD
Cabazitaxel—Lacrimation increased—Epirubicin—thyroid cancer	0.000701	0.00228	CcSEcCtD
Cabazitaxel—Leukopenia—Sorafenib—thyroid cancer	0.000684	0.00223	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Epirubicin—thyroid cancer	0.000683	0.00223	CcSEcCtD
Cabazitaxel—Cough—Sorafenib—thyroid cancer	0.000667	0.00217	CcSEcCtD
Cabazitaxel—Asthenia—Vandetanib—thyroid cancer	0.000663	0.00216	CcSEcCtD
Cabazitaxel—Rectal haemorrhage—Doxorubicin—thyroid cancer	0.000662	0.00216	CcSEcCtD
Cabazitaxel—Hypertension—Sorafenib—thyroid cancer	0.00066	0.00215	CcSEcCtD
Cabazitaxel—Cellulitis—Doxorubicin—thyroid cancer	0.000658	0.00214	CcSEcCtD
Cabazitaxel—Arthralgia—Sorafenib—thyroid cancer	0.000651	0.00212	CcSEcCtD
Cabazitaxel—Myalgia—Sorafenib—thyroid cancer	0.000651	0.00212	CcSEcCtD
Cabazitaxel—Lacrimation increased—Doxorubicin—thyroid cancer	0.000649	0.00211	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.000646	0.00211	CcSEcCtD
Cabazitaxel—Dry mouth—Sorafenib—thyroid cancer	0.000636	0.00207	CcSEcCtD
Cabazitaxel—Diarrhoea—Vandetanib—thyroid cancer	0.000633	0.00206	CcSEcCtD
Cabazitaxel—Blood bilirubin increased—Doxorubicin—thyroid cancer	0.000632	0.00206	CcSEcCtD
Cabazitaxel—Cystitis noninfective—Epirubicin—thyroid cancer	0.000631	0.00206	CcSEcCtD
Cabazitaxel—Cystitis—Epirubicin—thyroid cancer	0.000624	0.00203	CcSEcCtD
Cabazitaxel—Colitis—Epirubicin—thyroid cancer	0.00062	0.00202	CcSEcCtD
Cabazitaxel—Infection—Sorafenib—thyroid cancer	0.00062	0.00202	CcSEcCtD
Cabazitaxel—Candida infection—Epirubicin—thyroid cancer	0.000617	0.00201	CcSEcCtD
Cabazitaxel—Nervous system disorder—Sorafenib—thyroid cancer	0.000612	0.00199	CcSEcCtD
Cabazitaxel—Dizziness—Vandetanib—thyroid cancer	0.000612	0.00199	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Sorafenib—thyroid cancer	0.000611	0.00199	CcSEcCtD
Cabazitaxel—Skin disorder—Sorafenib—thyroid cancer	0.000606	0.00197	CcSEcCtD
Cabazitaxel—Anorexia—Sorafenib—thyroid cancer	0.000595	0.00194	CcSEcCtD
Cabazitaxel—Vomiting—Vandetanib—thyroid cancer	0.000588	0.00192	CcSEcCtD
Cabazitaxel—Bladder pain—Epirubicin—thyroid cancer	0.000584	0.0019	CcSEcCtD
Cabazitaxel—Cystitis noninfective—Doxorubicin—thyroid cancer	0.000584	0.0019	CcSEcCtD
Cabazitaxel—Headache—Vandetanib—thyroid cancer	0.000579	0.00189	CcSEcCtD
Cabazitaxel—Cystitis—Doxorubicin—thyroid cancer	0.000577	0.00188	CcSEcCtD
Cabazitaxel—Colitis—Doxorubicin—thyroid cancer	0.000574	0.00187	CcSEcCtD
Cabazitaxel—Candida infection—Doxorubicin—thyroid cancer	0.000571	0.00186	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.000568	0.00185	CcSEcCtD
Cabazitaxel—ABCB1—trachea—thyroid cancer	0.000567	0.00717	CbGeAlD
Cabazitaxel—ABCG2—lymph node—thyroid cancer	0.000565	0.00714	CbGeAlD
Cabazitaxel—Sepsis—Epirubicin—thyroid cancer	0.000561	0.00183	CcSEcCtD
Cabazitaxel—Dyspnoea—Sorafenib—thyroid cancer	0.000556	0.00181	CcSEcCtD
Cabazitaxel—Nausea—Vandetanib—thyroid cancer	0.000549	0.00179	CcSEcCtD
Cabazitaxel—Dyspepsia—Sorafenib—thyroid cancer	0.000549	0.00179	CcSEcCtD
Cabazitaxel—Decreased appetite—Sorafenib—thyroid cancer	0.000542	0.00177	CcSEcCtD
Cabazitaxel—Bladder pain—Doxorubicin—thyroid cancer	0.000541	0.00176	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.000539	0.00175	CcSEcCtD
Cabazitaxel—Fatigue—Sorafenib—thyroid cancer	0.000538	0.00175	CcSEcCtD
Cabazitaxel—Constipation—Sorafenib—thyroid cancer	0.000533	0.00174	CcSEcCtD
Cabazitaxel—Pain—Sorafenib—thyroid cancer	0.000533	0.00174	CcSEcCtD
Cabazitaxel—TUBB4A—Orphan transporters—RXRA—thyroid cancer	0.000527	0.005	CbGpPWpGaD
Cabazitaxel—TUBB4A—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.000524	0.00497	CbGpPWpGaD
Cabazitaxel—Sepsis—Doxorubicin—thyroid cancer	0.000519	0.00169	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—PCM1—thyroid cancer	0.000519	0.00492	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00051	0.00166	CcSEcCtD
Cabazitaxel—Renal failure acute—Epirubicin—thyroid cancer	0.000508	0.00166	CcSEcCtD
Cabazitaxel—Hot flush—Epirubicin—thyroid cancer	0.000501	0.00163	CcSEcCtD
Cabazitaxel—CYP3A5—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000499	0.00473	CbGpPWpGaD
Cabazitaxel—Menopausal symptoms—Epirubicin—thyroid cancer	0.000497	0.00162	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000493	0.00468	CbGpPWpGaD
Cabazitaxel—Body temperature increased—Sorafenib—thyroid cancer	0.000493	0.00161	CcSEcCtD
Cabazitaxel—Abdominal pain—Sorafenib—thyroid cancer	0.000493	0.00161	CcSEcCtD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000487	0.00462	CbGpPWpGaD
Cabazitaxel—TUBB4B—G2/M Transition—CDK1—thyroid cancer	0.000486	0.00461	CbGpPWpGaD
Cabazitaxel—TUBB4B—Orphan transporters—RXRA—thyroid cancer	0.000482	0.00458	CbGpPWpGaD
Cabazitaxel—Cardiac failure—Epirubicin—thyroid cancer	0.000481	0.00157	CcSEcCtD
Cabazitaxel—TUBB4B—Mitotic G2-G2/M phases—CDK1—thyroid cancer	0.00048	0.00455	CbGpPWpGaD
Cabazitaxel—Lethargy—Epirubicin—thyroid cancer	0.000479	0.00156	CcSEcCtD
Cabazitaxel—Renal failure acute—Doxorubicin—thyroid cancer	0.00047	0.00153	CcSEcCtD
Cabazitaxel—Pain in extremity—Epirubicin—thyroid cancer	0.000469	0.00153	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Epirubicin—thyroid cancer	0.000469	0.00153	CcSEcCtD
Cabazitaxel—Hot flush—Doxorubicin—thyroid cancer	0.000464	0.00151	CcSEcCtD
Cabazitaxel—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00046	0.0015	CcSEcCtD
Cabazitaxel—Hypersensitivity—Sorafenib—thyroid cancer	0.00046	0.0015	CcSEcCtD
Cabazitaxel—ABCB1—thyroid gland—thyroid cancer	0.000449	0.00567	CbGeAlD
Cabazitaxel—Asthenia—Sorafenib—thyroid cancer	0.000448	0.00146	CcSEcCtD
Cabazitaxel—Cardiac arrest—Epirubicin—thyroid cancer	0.000446	0.00145	CcSEcCtD
Cabazitaxel—Cardiac failure—Doxorubicin—thyroid cancer	0.000445	0.00145	CcSEcCtD
Cabazitaxel—Lethargy—Doxorubicin—thyroid cancer	0.000443	0.00144	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—PCM1—thyroid cancer	0.000441	0.00418	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metapathway biotransformation—CHST14—thyroid cancer	0.00044	0.00417	CbGpPWpGaD
Cabazitaxel—Dehydration—Epirubicin—thyroid cancer	0.000436	0.00142	CcSEcCtD
Cabazitaxel—Gastrointestinal haemorrhage—Doxorubicin—thyroid cancer	0.000434	0.00141	CcSEcCtD
Cabazitaxel—Pain in extremity—Doxorubicin—thyroid cancer	0.000434	0.00141	CcSEcCtD
Cabazitaxel—Dry skin—Epirubicin—thyroid cancer	0.00043	0.0014	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Epirubicin—thyroid cancer	0.000428	0.0014	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Epirubicin—thyroid cancer	0.000428	0.0014	CcSEcCtD
Cabazitaxel—Hypokalaemia—Epirubicin—thyroid cancer	0.000427	0.00139	CcSEcCtD
Cabazitaxel—Diarrhoea—Sorafenib—thyroid cancer	0.000427	0.00139	CcSEcCtD
Cabazitaxel—Breast disorder—Epirubicin—thyroid cancer	0.000424	0.00138	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Epirubicin—thyroid cancer	0.000422	0.00138	CcSEcCtD
Cabazitaxel—Gastritis—Epirubicin—thyroid cancer	0.000415	0.00135	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Epirubicin—thyroid cancer	0.000414	0.00135	CcSEcCtD
Cabazitaxel—Cardiac arrest—Doxorubicin—thyroid cancer	0.000413	0.00134	CcSEcCtD
Cabazitaxel—Dizziness—Sorafenib—thyroid cancer	0.000413	0.00134	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000409	0.00388	CbGpPWpGaD
Cabazitaxel—Abdominal distension—Epirubicin—thyroid cancer	0.000408	0.00133	CcSEcCtD
Cabazitaxel—Influenza—Epirubicin—thyroid cancer	0.000405	0.00132	CcSEcCtD
Cabazitaxel—Dehydration—Doxorubicin—thyroid cancer	0.000404	0.00131	CcSEcCtD
Cabazitaxel—ABCB1—head—thyroid cancer	0.000398	0.00503	CbGeAlD
Cabazitaxel—Dry skin—Doxorubicin—thyroid cancer	0.000398	0.0013	CcSEcCtD
Cabazitaxel—Vomiting—Sorafenib—thyroid cancer	0.000397	0.00129	CcSEcCtD
Cabazitaxel—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000396	0.00129	CcSEcCtD
Cabazitaxel—Orthostatic hypotension—Doxorubicin—thyroid cancer	0.000396	0.00129	CcSEcCtD
Cabazitaxel—Hypokalaemia—Doxorubicin—thyroid cancer	0.000395	0.00129	CcSEcCtD
Cabazitaxel—Breast disorder—Doxorubicin—thyroid cancer	0.000392	0.00128	CcSEcCtD
Cabazitaxel—Aspartate aminotransferase increased—Doxorubicin—thyroid cancer	0.000391	0.00127	CcSEcCtD
Cabazitaxel—Headache—Sorafenib—thyroid cancer	0.000391	0.00127	CcSEcCtD
Cabazitaxel—TUBB2A—Signaling events mediated by HDAC Class III—TP53—thyroid cancer	0.000389	0.00369	CbGpPWpGaD
Cabazitaxel—Gastritis—Doxorubicin—thyroid cancer	0.000384	0.00125	CcSEcCtD
Cabazitaxel—Alanine aminotransferase increased—Doxorubicin—thyroid cancer	0.000383	0.00125	CcSEcCtD
Cabazitaxel—CYP2C8—Metapathway biotransformation—CHST14—thyroid cancer	0.000381	0.00361	CbGpPWpGaD
Cabazitaxel—Dysuria—Epirubicin—thyroid cancer	0.000379	0.00124	CcSEcCtD
Cabazitaxel—Neutropenia—Epirubicin—thyroid cancer	0.000379	0.00124	CcSEcCtD
Cabazitaxel—Abdominal distension—Doxorubicin—thyroid cancer	0.000378	0.00123	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000377	0.00123	CcSEcCtD
Cabazitaxel—ABCB1—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000376	0.00357	CbGpPWpGaD
Cabazitaxel—Influenza—Doxorubicin—thyroid cancer	0.000375	0.00122	CcSEcCtD
Cabazitaxel—Pollakiuria—Epirubicin—thyroid cancer	0.000375	0.00122	CcSEcCtD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—PCM1—thyroid cancer	0.000374	0.00355	CbGpPWpGaD
Cabazitaxel—Nausea—Sorafenib—thyroid cancer	0.000371	0.00121	CcSEcCtD
Cabazitaxel—Weight decreased—Epirubicin—thyroid cancer	0.000367	0.00119	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Epirubicin—thyroid cancer	0.000366	0.00119	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle—PCM1—thyroid cancer	0.000365	0.00347	CbGpPWpGaD
Cabazitaxel—Pneumonia—Epirubicin—thyroid cancer	0.000364	0.00118	CcSEcCtD
Cabazitaxel—Infestation—Epirubicin—thyroid cancer	0.000361	0.00118	CcSEcCtD
Cabazitaxel—Infestation NOS—Epirubicin—thyroid cancer	0.000361	0.00118	CcSEcCtD
Cabazitaxel—Renal failure—Epirubicin—thyroid cancer	0.000355	0.00116	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000354	0.00115	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000354	0.00336	CbGpPWpGaD
Cabazitaxel—CYP3A4—Farnesoid X Receptor  Pathway—RXRA—thyroid cancer	0.000352	0.00334	CbGpPWpGaD
Cabazitaxel—Urinary tract infection—Epirubicin—thyroid cancer	0.000351	0.00114	CcSEcCtD
Cabazitaxel—Conjunctivitis—Epirubicin—thyroid cancer	0.000351	0.00114	CcSEcCtD
Cabazitaxel—Dysuria—Doxorubicin—thyroid cancer	0.000351	0.00114	CcSEcCtD
Cabazitaxel—Neutropenia—Doxorubicin—thyroid cancer	0.000351	0.00114	CcSEcCtD
Cabazitaxel—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.000349	0.00114	CcSEcCtD
Cabazitaxel—Pollakiuria—Doxorubicin—thyroid cancer	0.000347	0.00113	CcSEcCtD
Cabazitaxel—Haematuria—Epirubicin—thyroid cancer	0.000345	0.00112	CcSEcCtD
Cabazitaxel—Weight decreased—Doxorubicin—thyroid cancer	0.000339	0.00111	CcSEcCtD
Cabazitaxel—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000338	0.0011	CcSEcCtD
Cabazitaxel—Pneumonia—Doxorubicin—thyroid cancer	0.000336	0.0011	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—CP—thyroid cancer	0.000335	0.00318	CbGpPWpGaD
Cabazitaxel—Infestation—Doxorubicin—thyroid cancer	0.000334	0.00109	CcSEcCtD
Cabazitaxel—Infestation NOS—Doxorubicin—thyroid cancer	0.000334	0.00109	CcSEcCtD
Cabazitaxel—TUBB4B—Cell Cycle—PCM1—thyroid cancer	0.000334	0.00317	CbGpPWpGaD
Cabazitaxel—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—EPO—thyroid cancer	0.000334	0.00317	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000333	0.00316	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000333	0.00316	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—PRKAR1A—thyroid cancer	0.00033	0.00313	CbGpPWpGaD
Cabazitaxel—Renal failure—Doxorubicin—thyroid cancer	0.000329	0.00107	CcSEcCtD
Cabazitaxel—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000328	0.00107	CcSEcCtD
Cabazitaxel—Urinary tract infection—Doxorubicin—thyroid cancer	0.000325	0.00106	CcSEcCtD
Cabazitaxel—Conjunctivitis—Doxorubicin—thyroid cancer	0.000325	0.00106	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Epirubicin—thyroid cancer	0.000323	0.00105	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Epirubicin—thyroid cancer	0.00032	0.00104	CcSEcCtD
Cabazitaxel—Oedema peripheral—Epirubicin—thyroid cancer	0.00032	0.00104	CcSEcCtD
Cabazitaxel—Haematuria—Doxorubicin—thyroid cancer	0.000319	0.00104	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Epirubicin—thyroid cancer	0.000319	0.00104	CcSEcCtD
Cabazitaxel—Urethral disorder—Epirubicin—thyroid cancer	0.000318	0.00104	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—TPR—thyroid cancer	0.000317	0.00301	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00031	0.00294	CbGpPWpGaD
Cabazitaxel—Eye disorder—Epirubicin—thyroid cancer	0.000303	0.000988	CcSEcCtD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000303	0.00287	CbGpPWpGaD
Cabazitaxel—Tinnitus—Epirubicin—thyroid cancer	0.000303	0.000986	CcSEcCtD
Cabazitaxel—CYP3A5—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000302	0.00286	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000301	0.00286	CbGpPWpGaD
Cabazitaxel—Cardiac disorder—Epirubicin—thyroid cancer	0.000301	0.000981	CcSEcCtD
Cabazitaxel—Flushing—Epirubicin—thyroid cancer	0.000301	0.000981	CcSEcCtD
Cabazitaxel—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000299	0.000973	CcSEcCtD
Cabazitaxel—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000297	0.000966	CcSEcCtD
Cabazitaxel—Oedema peripheral—Doxorubicin—thyroid cancer	0.000296	0.000964	CcSEcCtD
Cabazitaxel—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000295	0.000961	CcSEcCtD
Cabazitaxel—Angiopathy—Epirubicin—thyroid cancer	0.000294	0.000959	CcSEcCtD
Cabazitaxel—Urethral disorder—Doxorubicin—thyroid cancer	0.000294	0.000959	CcSEcCtD
Cabazitaxel—Immune system disorder—Epirubicin—thyroid cancer	0.000293	0.000955	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Epirubicin—thyroid cancer	0.000292	0.000953	CcSEcCtD
Cabazitaxel—Chills—Epirubicin—thyroid cancer	0.000291	0.000949	CcSEcCtD
Cabazitaxel—Arrhythmia—Epirubicin—thyroid cancer	0.00029	0.000944	CcSEcCtD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.00029	0.00275	CbGpPWpGaD
Cabazitaxel—Alopecia—Epirubicin—thyroid cancer	0.000287	0.000934	CcSEcCtD
Cabazitaxel—Mental disorder—Epirubicin—thyroid cancer	0.000284	0.000926	CcSEcCtD
Cabazitaxel—Erythema—Epirubicin—thyroid cancer	0.000282	0.00092	CcSEcCtD
Cabazitaxel—Malnutrition—Epirubicin—thyroid cancer	0.000282	0.00092	CcSEcCtD
Cabazitaxel—Eye disorder—Doxorubicin—thyroid cancer	0.000281	0.000914	CcSEcCtD
Cabazitaxel—Tinnitus—Doxorubicin—thyroid cancer	0.00028	0.000912	CcSEcCtD
Cabazitaxel—ABCB1—lymph node—thyroid cancer	0.000279	0.00352	CbGeAlD
Cabazitaxel—Flushing—Doxorubicin—thyroid cancer	0.000279	0.000908	CcSEcCtD
Cabazitaxel—Cardiac disorder—Doxorubicin—thyroid cancer	0.000279	0.000908	CcSEcCtD
Cabazitaxel—Dysgeusia—Epirubicin—thyroid cancer	0.000277	0.000901	CcSEcCtD
Cabazitaxel—Back pain—Epirubicin—thyroid cancer	0.000273	0.00089	CcSEcCtD
Cabazitaxel—Angiopathy—Doxorubicin—thyroid cancer	0.000272	0.000888	CcSEcCtD
Cabazitaxel—Muscle spasms—Epirubicin—thyroid cancer	0.000272	0.000885	CcSEcCtD
Cabazitaxel—Immune system disorder—Doxorubicin—thyroid cancer	0.000271	0.000884	CcSEcCtD
Cabazitaxel—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000271	0.000882	CcSEcCtD
Cabazitaxel—Chills—Doxorubicin—thyroid cancer	0.000269	0.000878	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—TPR—thyroid cancer	0.000269	0.00256	CbGpPWpGaD
Cabazitaxel—Arrhythmia—Doxorubicin—thyroid cancer	0.000268	0.000874	CcSEcCtD
Cabazitaxel—Alopecia—Doxorubicin—thyroid cancer	0.000265	0.000864	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—EPO—thyroid cancer	0.000263	0.0025	CbGpPWpGaD
Cabazitaxel—Mental disorder—Doxorubicin—thyroid cancer	0.000263	0.000857	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Epirubicin—thyroid cancer	0.000262	0.000854	CcSEcCtD
Cabazitaxel—Erythema—Doxorubicin—thyroid cancer	0.000261	0.000852	CcSEcCtD
Cabazitaxel—Malnutrition—Doxorubicin—thyroid cancer	0.000261	0.000852	CcSEcCtD
Cabazitaxel—CYP2C8—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.000261	0.00248	CbGpPWpGaD
Cabazitaxel—Anaemia—Epirubicin—thyroid cancer	0.000261	0.000851	CcSEcCtD
Cabazitaxel—Dysgeusia—Doxorubicin—thyroid cancer	0.000256	0.000834	CcSEcCtD
Cabazitaxel—Malaise—Epirubicin—thyroid cancer	0.000255	0.00083	CcSEcCtD
Cabazitaxel—Vertigo—Epirubicin—thyroid cancer	0.000254	0.000827	CcSEcCtD
Cabazitaxel—Leukopenia—Epirubicin—thyroid cancer	0.000253	0.000824	CcSEcCtD
Cabazitaxel—Back pain—Doxorubicin—thyroid cancer	0.000253	0.000824	CcSEcCtD
Cabazitaxel—Muscle spasms—Doxorubicin—thyroid cancer	0.000251	0.000819	CcSEcCtD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—TPR—thyroid cancer	0.00025	0.00237	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000249	0.00236	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000249	0.00236	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—CP—thyroid cancer	0.000249	0.00236	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—CP—thyroid cancer	0.000249	0.00236	CbGpPWpGaD
Cabazitaxel—SLCO1B3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000249	0.00236	CbGpPWpGaD
Cabazitaxel—Cough—Epirubicin—thyroid cancer	0.000247	0.000803	CcSEcCtD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000245	0.00233	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000245	0.00233	CbGpPWpGaD
Cabazitaxel—CYP3A5—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000245	0.00232	CbGpPWpGaD
Cabazitaxel—Hypertension—Epirubicin—thyroid cancer	0.000244	0.000795	CcSEcCtD
Cabazitaxel—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000243	0.00079	CcSEcCtD
Cabazitaxel—Anaemia—Doxorubicin—thyroid cancer	0.000242	0.000787	CcSEcCtD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000241	0.00228	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000241	0.00228	CbGpPWpGaD
Cabazitaxel—Arthralgia—Epirubicin—thyroid cancer	0.00024	0.000784	CcSEcCtD
Cabazitaxel—Chest pain—Epirubicin—thyroid cancer	0.00024	0.000784	CcSEcCtD
Cabazitaxel—Myalgia—Epirubicin—thyroid cancer	0.00024	0.000784	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.00024	0.00228	CbGpPWpGaD
Cabazitaxel—Anxiety—Epirubicin—thyroid cancer	0.00024	0.000781	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000239	0.000778	CcSEcCtD
Cabazitaxel—Discomfort—Epirubicin—thyroid cancer	0.000238	0.000774	CcSEcCtD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000237	0.00225	CbGpPWpGaD
Cabazitaxel—Malaise—Doxorubicin—thyroid cancer	0.000236	0.000768	CcSEcCtD
Cabazitaxel—Dry mouth—Epirubicin—thyroid cancer	0.000235	0.000766	CcSEcCtD
Cabazitaxel—Vertigo—Doxorubicin—thyroid cancer	0.000235	0.000765	CcSEcCtD
Cabazitaxel—Leukopenia—Doxorubicin—thyroid cancer	0.000234	0.000762	CcSEcCtD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000233	0.00221	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—CP—thyroid cancer	0.000233	0.00221	CbGpPWpGaD
Cabazitaxel—Confusional state—Epirubicin—thyroid cancer	0.000232	0.000757	CcSEcCtD
Cabazitaxel—CYP3A4—Constitutive Androstane Receptor Pathway—RXRA—thyroid cancer	0.000232	0.0022	CbGpPWpGaD
Cabazitaxel—Oedema—Epirubicin—thyroid cancer	0.000231	0.000751	CcSEcCtD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000229	0.00218	CbGpPWpGaD
Cabazitaxel—Infection—Epirubicin—thyroid cancer	0.000229	0.000746	CcSEcCtD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—TPR—thyroid cancer	0.000228	0.00217	CbGpPWpGaD
Cabazitaxel—Cough—Doxorubicin—thyroid cancer	0.000228	0.000743	CcSEcCtD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000228	0.00216	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000228	0.00216	CbGpPWpGaD
Cabazitaxel—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000226	0.00215	CbGpPWpGaD
Cabazitaxel—Nervous system disorder—Epirubicin—thyroid cancer	0.000226	0.000737	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Epirubicin—thyroid cancer	0.000226	0.000735	CcSEcCtD
Cabazitaxel—Hypertension—Doxorubicin—thyroid cancer	0.000226	0.000735	CcSEcCtD
Cabazitaxel—Tachycardia—Epirubicin—thyroid cancer	0.000225	0.000733	CcSEcCtD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000224	0.00213	CbGpPWpGaD
Cabazitaxel—Skin disorder—Epirubicin—thyroid cancer	0.000224	0.00073	CcSEcCtD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000224	0.00212	CbGpPWpGaD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000224	0.00212	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TPR—thyroid cancer	0.000223	0.00212	CbGpPWpGaD
Cabazitaxel—Arthralgia—Doxorubicin—thyroid cancer	0.000223	0.000725	CcSEcCtD
Cabazitaxel—Myalgia—Doxorubicin—thyroid cancer	0.000223	0.000725	CcSEcCtD
Cabazitaxel—Chest pain—Doxorubicin—thyroid cancer	0.000223	0.000725	CcSEcCtD
Cabazitaxel—Anxiety—Doxorubicin—thyroid cancer	0.000222	0.000722	CcSEcCtD
Cabazitaxel—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000221	0.00072	CcSEcCtD
Cabazitaxel—Discomfort—Doxorubicin—thyroid cancer	0.00022	0.000716	CcSEcCtD
Cabazitaxel—Anorexia—Epirubicin—thyroid cancer	0.00022	0.000716	CcSEcCtD
Cabazitaxel—TUBA4A—Hemostasis—IFNA2—thyroid cancer	0.000219	0.00208	CbGpPWpGaD
Cabazitaxel—Dry mouth—Doxorubicin—thyroid cancer	0.000218	0.000709	CcSEcCtD
Cabazitaxel—Hypotension—Epirubicin—thyroid cancer	0.000215	0.000702	CcSEcCtD
Cabazitaxel—Confusional state—Doxorubicin—thyroid cancer	0.000215	0.000701	CcSEcCtD
Cabazitaxel—TUBA4A—Cell Cycle—CDK1—thyroid cancer	0.000215	0.00204	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—MINPP1—thyroid cancer	0.000214	0.00203	CbGpPWpGaD
Cabazitaxel—Oedema—Doxorubicin—thyroid cancer	0.000213	0.000695	CcSEcCtD
Cabazitaxel—Infection—Doxorubicin—thyroid cancer	0.000212	0.00069	CcSEcCtD
Cabazitaxel—CYP2C8—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000212	0.00201	CbGpPWpGaD
Cabazitaxel—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00021	0.000684	CcSEcCtD
Cabazitaxel—Nervous system disorder—Doxorubicin—thyroid cancer	0.000209	0.000682	CcSEcCtD
Cabazitaxel—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000209	0.00068	CcSEcCtD
Cabazitaxel—Tachycardia—Doxorubicin—thyroid cancer	0.000208	0.000678	CcSEcCtD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.000208	0.00197	CbGpPWpGaD
Cabazitaxel—Skin disorder—Doxorubicin—thyroid cancer	0.000207	0.000675	CcSEcCtD
Cabazitaxel—Paraesthesia—Epirubicin—thyroid cancer	0.000207	0.000674	CcSEcCtD
Cabazitaxel—Dyspnoea—Epirubicin—thyroid cancer	0.000206	0.00067	CcSEcCtD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000205	0.00194	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—CP—thyroid cancer	0.000205	0.00194	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metapathway biotransformation—CHST14—thyroid cancer	0.000205	0.00194	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TPR—thyroid cancer	0.000204	0.00194	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000204	0.00194	CbGpPWpGaD
Cabazitaxel—Anorexia—Doxorubicin—thyroid cancer	0.000203	0.000662	CcSEcCtD
Cabazitaxel—Dyspepsia—Epirubicin—thyroid cancer	0.000203	0.000661	CcSEcCtD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000201	0.00191	CbGpPWpGaD
Cabazitaxel—ABCG2—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000201	0.0019	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Epirubicin—thyroid cancer	0.0002	0.000653	CcSEcCtD
Cabazitaxel—Hypotension—Doxorubicin—thyroid cancer	0.000199	0.000649	CcSEcCtD
Cabazitaxel—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000199	0.000648	CcSEcCtD
Cabazitaxel—Fatigue—Epirubicin—thyroid cancer	0.000199	0.000648	CcSEcCtD
Cabazitaxel—Pain—Epirubicin—thyroid cancer	0.000197	0.000642	CcSEcCtD
Cabazitaxel—Constipation—Epirubicin—thyroid cancer	0.000197	0.000642	CcSEcCtD
Cabazitaxel—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000194	0.000633	CcSEcCtD
Cabazitaxel—Paraesthesia—Doxorubicin—thyroid cancer	0.000192	0.000624	CcSEcCtD
Cabazitaxel—Dyspnoea—Doxorubicin—thyroid cancer	0.00019	0.00062	CcSEcCtD
Cabazitaxel—Feeling abnormal—Epirubicin—thyroid cancer	0.00019	0.000619	CcSEcCtD
Cabazitaxel—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000189	0.000614	CcSEcCtD
Cabazitaxel—Dyspepsia—Doxorubicin—thyroid cancer	0.000188	0.000612	CcSEcCtD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—CP—thyroid cancer	0.000187	0.00178	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000187	0.00178	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000187	0.00177	CbGpPWpGaD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000187	0.00177	CbGpPWpGaD
Cabazitaxel—Decreased appetite—Doxorubicin—thyroid cancer	0.000185	0.000604	CcSEcCtD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000184	0.00175	CbGpPWpGaD
Cabazitaxel—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000184	0.0006	CcSEcCtD
Cabazitaxel—Fatigue—Doxorubicin—thyroid cancer	0.000184	0.000599	CcSEcCtD
Cabazitaxel—TUBB—Cell Cycle—CDK1—thyroid cancer	0.000183	0.00173	CbGpPWpGaD
Cabazitaxel—Pain—Doxorubicin—thyroid cancer	0.000182	0.000594	CcSEcCtD
Cabazitaxel—Constipation—Doxorubicin—thyroid cancer	0.000182	0.000594	CcSEcCtD
Cabazitaxel—Abdominal pain—Epirubicin—thyroid cancer	0.000182	0.000594	CcSEcCtD
Cabazitaxel—Body temperature increased—Epirubicin—thyroid cancer	0.000182	0.000594	CcSEcCtD
Cabazitaxel—SLCO1B3—Metabolism—NDUFA13—thyroid cancer	0.000182	0.00173	CbGpPWpGaD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00018	0.00171	CbGpPWpGaD
Cabazitaxel—Feeling abnormal—Doxorubicin—thyroid cancer	0.000176	0.000573	CcSEcCtD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000175	0.00166	CbGpPWpGaD
Cabazitaxel—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000174	0.000568	CcSEcCtD
Cabazitaxel—SLCO1B3—Metabolism—CHST14—thyroid cancer	0.000171	0.00162	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000171	0.00162	CbGpPWpGaD
Cabazitaxel—Hypersensitivity—Epirubicin—thyroid cancer	0.00017	0.000553	CcSEcCtD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000169	0.0016	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000169	0.0016	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000169	0.0016	CbGpPWpGaD
Cabazitaxel—Body temperature increased—Doxorubicin—thyroid cancer	0.000169	0.000549	CcSEcCtD
Cabazitaxel—Abdominal pain—Doxorubicin—thyroid cancer	0.000169	0.000549	CcSEcCtD
Cabazitaxel—SLCO1B1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000167	0.00159	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000166	0.00158	CbGpPWpGaD
Cabazitaxel—Asthenia—Epirubicin—thyroid cancer	0.000165	0.000539	CcSEcCtD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—TERT—thyroid cancer	0.000164	0.00155	CbGpPWpGaD
Cabazitaxel—Diarrhoea—Epirubicin—thyroid cancer	0.000158	0.000514	CcSEcCtD
Cabazitaxel—Hypersensitivity—Doxorubicin—thyroid cancer	0.000157	0.000512	CcSEcCtD
Cabazitaxel—TUBB6—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000157	0.00149	CbGpPWpGaD
Cabazitaxel—TUBB2B—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000157	0.00149	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—HIF1A—thyroid cancer	0.000157	0.00149	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TERT—thyroid cancer	0.000155	0.00147	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CDK1—thyroid cancer	0.000155	0.00147	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000153	0.00145	CbGpPWpGaD
Cabazitaxel—Asthenia—Doxorubicin—thyroid cancer	0.000153	0.000499	CcSEcCtD
Cabazitaxel—Dizziness—Epirubicin—thyroid cancer	0.000152	0.000497	CcSEcCtD
Cabazitaxel—TUBB3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000151	0.00144	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CDK1—thyroid cancer	0.000151	0.00143	CbGpPWpGaD
Cabazitaxel—CYP2C8—Arachidonic acid metabolism—PTGS2—thyroid cancer	0.00015	0.00142	CbGpPWpGaD
Cabazitaxel—TUBB2A—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000147	0.00139	CbGpPWpGaD
Cabazitaxel—Vomiting—Epirubicin—thyroid cancer	0.000147	0.000478	CcSEcCtD
Cabazitaxel—Diarrhoea—Doxorubicin—thyroid cancer	0.000146	0.000476	CcSEcCtD
Cabazitaxel—Headache—Epirubicin—thyroid cancer	0.000144	0.000471	CcSEcCtD
Cabazitaxel—SLCO1B1—Metabolism—MINPP1—thyroid cancer	0.000144	0.00136	CbGpPWpGaD
Cabazitaxel—TUBB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000143	0.00136	CbGpPWpGaD
Cabazitaxel—Dizziness—Doxorubicin—thyroid cancer	0.000141	0.00046	CcSEcCtD
Cabazitaxel—CYP3A4—Cytochrome P450 - arranged by substrate type—RXRA—thyroid cancer	0.00014	0.00133	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.00014	0.00133	CbGpPWpGaD
Cabazitaxel—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—thyroid cancer	0.000139	0.00132	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CDK1—thyroid cancer	0.000138	0.00131	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—HPGD—thyroid cancer	0.000138	0.00131	CbGpPWpGaD
Cabazitaxel—Nausea—Epirubicin—thyroid cancer	0.000137	0.000446	CcSEcCtD
Cabazitaxel—Vomiting—Doxorubicin—thyroid cancer	0.000136	0.000442	CcSEcCtD
Cabazitaxel—Headache—Doxorubicin—thyroid cancer	0.000134	0.000435	CcSEcCtD
Cabazitaxel—ABCG2—Metabolism—MINPP1—thyroid cancer	0.000133	0.00126	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TERT—thyroid cancer	0.000132	0.00125	CbGpPWpGaD
Cabazitaxel—CYP3A5—Biological oxidations—RXRA—thyroid cancer	0.00013	0.00123	CbGpPWpGaD
Cabazitaxel—TUBB4A—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000129	0.00122	CbGpPWpGaD
Cabazitaxel—Nausea—Doxorubicin—thyroid cancer	0.000127	0.000413	CcSEcCtD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000127	0.0012	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—NDUFA13—thyroid cancer	0.000122	0.00116	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—HPGD—thyroid cancer	0.00012	0.00113	CbGpPWpGaD
Cabazitaxel—TUBB4B—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000118	0.00112	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—CHST14—thyroid cancer	0.000115	0.00109	CbGpPWpGaD
Cabazitaxel—CYP3A4—Phase 1 - Functionalization of compounds—RXRA—thyroid cancer	0.000114	0.00108	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000114	0.00108	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000114	0.00108	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—NDUFA13—thyroid cancer	0.000113	0.00107	CbGpPWpGaD
Cabazitaxel—CYP2C8—Biological oxidations—RXRA—thyroid cancer	0.000113	0.00107	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	0.000112	0.00106	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000112	0.00106	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TERT—thyroid cancer	0.000109	0.00103	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—CHST14—thyroid cancer	0.000106	0.00101	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000106	0.00101	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—CP—thyroid cancer	0.000105	0.000998	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000105	0.000998	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000104	0.000982	CbGpPWpGaD
Cabazitaxel—TUBA4A—Platelet activation, signaling and aggregation—AKT1—thyroid cancer	0.000102	0.00097	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	0.0001	0.000949	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TERT—thyroid cancer	9.97e-05	0.000946	CbGpPWpGaD
Cabazitaxel—ABCG2—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	9.74e-05	0.000924	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—MINPP1—thyroid cancer	9.54e-05	0.000905	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—HPGD—thyroid cancer	9.27e-05	0.000879	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	9.01e-05	0.000855	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—CCND1—thyroid cancer	8.94e-05	0.000848	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—HPGD—thyroid cancer	8.58e-05	0.000814	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	8.51e-05	0.000807	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle, Mitotic—CCND1—thyroid cancer	8.5e-05	0.000807	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—MINPP1—thyroid cancer	8.27e-05	0.000784	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—NRAS—thyroid cancer	8.16e-05	0.000774	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—NDUFA13—thyroid cancer	8.11e-05	0.00077	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—TPR—thyroid cancer	7.92e-05	0.000752	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	7.88e-05	0.000747	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PRKAR1A—thyroid cancer	7.8e-05	0.000739	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—CHST14—thyroid cancer	7.63e-05	0.000724	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—CCND1—thyroid cancer	7.6e-05	0.000721	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	7.52e-05	0.000713	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—MINPP1—thyroid cancer	7.2e-05	0.000683	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Transmembrane transport of small molecules—RXRA—thyroid cancer	7.15e-05	0.000678	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	7.07e-05	0.00067	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle, Mitotic—CCND1—thyroid cancer	7.05e-05	0.000668	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—NDUFA13—thyroid cancer	7.03e-05	0.000667	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—KRAS—thyroid cancer	7.02e-05	0.000666	CbGpPWpGaD
Cabazitaxel—ABCG2—Transmembrane transport of small molecules—RXRA—thyroid cancer	6.62e-05	0.000628	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—CHST14—thyroid cancer	6.61e-05	0.000627	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle, Mitotic—CCND1—thyroid cancer	6.44e-05	0.000611	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—CCND1—thyroid cancer	6.3e-05	0.000598	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—TP53—thyroid cancer	6.24e-05	0.000592	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—HPGD—thyroid cancer	6.15e-05	0.000583	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—NDUFA13—thyroid cancer	6.12e-05	0.000581	CbGpPWpGaD
Cabazitaxel—CYP3A4—Biological oxidations—RXRA—thyroid cancer	6.04e-05	0.000573	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—HRAS—thyroid cancer	5.97e-05	0.000566	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—SLC5A5—thyroid cancer	5.93e-05	0.000563	CbGpPWpGaD
Cabazitaxel—TUBA4A—Cell Cycle—TP53—thyroid cancer	5.89e-05	0.000559	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—CCND1—thyroid cancer	5.76e-05	0.000547	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—CHST14—thyroid cancer	5.76e-05	0.000546	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	5.69e-05	0.00054	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	5.69e-05	0.00054	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	5.6e-05	0.000531	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	5.56e-05	0.000527	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—HPGD—thyroid cancer	5.33e-05	0.000505	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—TPR—thyroid cancer	5.32e-05	0.000505	CbGpPWpGaD
Cabazitaxel—TUBA4A—Hemostasis—AKT1—thyroid cancer	5.27e-05	0.0005	CbGpPWpGaD
Cabazitaxel—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	5.27e-05	0.000499	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PRKAR1A—thyroid cancer	5.24e-05	0.000497	CbGpPWpGaD
Cabazitaxel—TUBB—Cell Cycle—TP53—thyroid cancer	5.01e-05	0.000475	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—RXRA—thyroid cancer	4.98e-05	0.000473	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—TPR—thyroid cancer	4.93e-05	0.000468	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PRKAR1A—thyroid cancer	4.85e-05	0.00046	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	4.85e-05	0.00046	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	4.75e-05	0.00045	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—HPGD—thyroid cancer	4.64e-05	0.00044	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	4.48e-05	0.000425	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—MINPP1—thyroid cancer	4.44e-05	0.000421	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—RXRA—thyroid cancer	4.32e-05	0.00041	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	4.26e-05	0.000404	CbGpPWpGaD
Cabazitaxel—TUBB4A—Cell Cycle—TP53—thyroid cancer	4.15e-05	0.000394	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	4.05e-05	0.000384	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—SLC5A5—thyroid cancer	3.99e-05	0.000378	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	3.9e-05	0.00037	CbGpPWpGaD
Cabazitaxel—TUBB4B—Cell Cycle—TP53—thyroid cancer	3.8e-05	0.00036	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—NDUFA13—thyroid cancer	3.77e-05	0.000358	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	3.73e-05	0.000354	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—SLC5A5—thyroid cancer	3.69e-05	0.00035	CbGpPWpGaD
Cabazitaxel—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	3.58e-05	0.000339	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—CHST14—thyroid cancer	3.55e-05	0.000336	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—TPR—thyroid cancer	3.53e-05	0.000335	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PRKAR1A—thyroid cancer	3.47e-05	0.00033	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—RXRA—thyroid cancer	3.35e-05	0.000318	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	3.26e-05	0.000309	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PPARG—thyroid cancer	3.15e-05	0.000298	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—RXRA—thyroid cancer	3.1e-05	0.000294	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—TPR—thyroid cancer	3.06e-05	0.00029	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PRKAR1A—thyroid cancer	3.01e-05	0.000285	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	3e-05	0.000284	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—HPGD—thyroid cancer	2.86e-05	0.000271	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—thyroid cancer	2.73e-05	0.000259	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—TPR—thyroid cancer	2.67e-05	0.000253	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	2.66e-05	0.000253	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—SLC5A5—thyroid cancer	2.64e-05	0.000251	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PRKAR1A—thyroid cancer	2.62e-05	0.000249	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTGS2—thyroid cancer	2.48e-05	0.000235	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—SLC5A5—thyroid cancer	2.29e-05	0.000217	CbGpPWpGaD
Cabazitaxel—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	2.25e-05	0.000213	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—RXRA—thyroid cancer	2.22e-05	0.000211	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—PTEN—thyroid cancer	2.16e-05	0.000205	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—thyroid cancer	2.15e-05	0.000204	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PPARG—thyroid cancer	2.11e-05	0.000201	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—SLC5A5—thyroid cancer	2e-05	0.000189	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PPARG—thyroid cancer	1.96e-05	0.000186	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—RXRA—thyroid cancer	1.92e-05	0.000183	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—thyroid cancer	1.87e-05	0.000178	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—RXRA—thyroid cancer	1.68e-05	0.000159	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTGS2—thyroid cancer	1.66e-05	0.000158	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—TPR—thyroid cancer	1.64e-05	0.000156	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PRKAR1A—thyroid cancer	1.62e-05	0.000153	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTGS2—thyroid cancer	1.54e-05	0.000146	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—PTEN—thyroid cancer	1.45e-05	0.000138	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PPARG—thyroid cancer	1.4e-05	0.000133	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—PTEN—thyroid cancer	1.34e-05	0.000127	CbGpPWpGaD
Cabazitaxel—SLCO1B3—Metabolism—AKT1—thyroid cancer	1.24e-05	0.000118	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—SLC5A5—thyroid cancer	1.23e-05	0.000117	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PPARG—thyroid cancer	1.21e-05	0.000115	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTGS2—thyroid cancer	1.1e-05	0.000105	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PPARG—thyroid cancer	1.06e-05	0.0001	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—RXRA—thyroid cancer	1.03e-05	9.8e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—PTEN—thyroid cancer	9.62e-06	9.13e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTGS2—thyroid cancer	9.56e-06	9.07e-05	CbGpPWpGaD
Cabazitaxel—SLCO1B1—Metabolism—AKT1—thyroid cancer	8.36e-06	7.93e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—PTEN—thyroid cancer	8.33e-06	7.91e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTGS2—thyroid cancer	8.33e-06	7.9e-05	CbGpPWpGaD
Cabazitaxel—ABCG2—Metabolism—AKT1—thyroid cancer	7.74e-06	7.34e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—PTEN—thyroid cancer	7.26e-06	6.89e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PPARG—thyroid cancer	6.52e-06	6.19e-05	CbGpPWpGaD
Cabazitaxel—CYP3A5—Metabolism—AKT1—thyroid cancer	5.55e-06	5.26e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTGS2—thyroid cancer	5.13e-06	4.87e-05	CbGpPWpGaD
Cabazitaxel—CYP2C8—Metabolism—AKT1—thyroid cancer	4.8e-06	4.56e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—PTEN—thyroid cancer	4.47e-06	4.24e-05	CbGpPWpGaD
Cabazitaxel—ABCB1—Metabolism—AKT1—thyroid cancer	4.18e-06	3.97e-05	CbGpPWpGaD
Cabazitaxel—CYP3A4—Metabolism—AKT1—thyroid cancer	2.58e-06	2.45e-05	CbGpPWpGaD
